ArticleJTCVS open2026
National trends in adult cardiac surgery inpatient costs: A decade in review.
Article in JTCVS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To characterize national trends in inpatient costs associated with adult cardiac surgery from 2013 to 2022 and identify factors independently associated with increased hospitalization expenditures. Methods: All hospitalizations entailing major cardiac operations (coronary artery bypass grafting, valve procedures [open and transcatheter], aortic repair) were identified in the 2013-2022 National Inpatient Sample. Temporal trends were evaluated using the Cuzick test for trend (nptrend), and multivariable linear regression was used to identify factors associated contemporary costs (2022). Results: Among an estimated 3,323,645 admissions, annual volume increased from 293,645 to 361,355 (nptrend = 0.01). Elective hospitalization costs increased from $8.1 to $12.9 billion (nptrend < 0.001), with median per-admission costs increasing from $41,000 to $48,000 (nptrend < 0.001). For nonelective hospitalizations, total costs rose from $8.3 to $10.4 billion (nptrend = 0.01), and median per-admission costs from $51,000 to $63,000 (nptrend < 0.001). The proportion of transcatheter valve procedures rose from 6.4% to 38.9% (nptrend < 0.001), whereas their median per-admission costs decreased. In 2022, Black race (β $9,300, 95% confidence interval [CI], $6700-$11,800) and care in the Western United States (β $12,800, 95% CI, $7600-$17,900) were associated with increased costs. Elective admission (β -$26,000, 95% CI, -$27,900 to -$24,200), older age (β -$1400 per decade, 95% CI, -$2100 to -$800), and lowest income quartile (β -$3200, 95% CI, -$5700 to -$800; ref: highest) were associated with lower costs. Conclusions: Inpatient cardiac surgery costs increased significantly over the decade. These trends, alongside increased use of transcatheter techniques and persistent disparities, underscore the need for systemic reform to ensure sustainable and equitable care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.